ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As is reported, the clonal cytogenetic changes of normal ABL protein caused by imatinib itself,[12] possibly devoted to the mechanism of CCA/Ph–AML after CML with TKIs therapy.